When evaluating decentralised clinical trial (DCT) platforms, two names frequently emerge: Castor EDC and Medable. Both are serious contenders, but they solve slightly different problems.
Whether you’re running a fully decentralised study, a hybrid trial, or a traditional setup with remote monitoring, the right choice depends on your specific needs, particularly whether you require home health coordination and advanced patient logistics, or a unified EDC plus eCOA plus eConsent platform.
Decentralised clinical trials span a spectrum: from fully remote (no site visits) to hybrid (some site, some remote). The right platform depends on where your study sits on that spectrum and whether you need home health logistics coordination. If running a truly decentralised programme with home visits and advanced patient coordination needs, Medable’s ecosystem may add value. If you need a straightforward, transparent alternative for unified EDC plus eCOA plus eConsent for hybrid or traditional designs, Castor is often simpler and more cost-effective.
| Feature | Castor EDC | Medable |
|---|---|---|
| Best for | Hybrid and traditional; unified EDC plus eCOA plus eConsent | Fully decentralised; home health coordination |
| Primary strength | All-in-one platform; no integration needed | Patient-first DCT; home logistics; telehealth |
| Native EDC | Yes (built-in) | Limited (integration often needed) |
| eCOA / ePRO | Yes (native, BYOD plus provisioned) | Yes (strong; patient app) |
| eConsent | Yes (remote, home-based, video-assisted) | Yes |
| Telehealth integration | Limited integration | Native and advanced |
| Home health and nursing | Not a primary focus | Native coordination |
| Wearable / sensor integration | Limited | Advanced |
| EU MDR / PMCF | Strong support | Not publicly documented |
| Pricing model | Predictable flat-rate study licensing, no per-subject fees | Pricing not publicly disclosed |
| Implementation complexity | Lower; no-code builder | Higher; integration-heavy |
| Academic / IIT support | Strong | Limited |
| Feature | Castor EDC | Medable | Advantage |
|---|---|---|---|
| Native EDC (built-in, no integration) | Full EDC with CRF builder, query management, audit trail | EDC available but often integrated with third-party systems | Castor |
| No-code eCOA / eConsent builder | Yes; visual flow designer; BYOD plus provisioned options | Limited no-code; requires more configuration | Castor |
| Remote eCOA (patient app, BYOD) | Full BYOD support; push notifications; offline capability | Strong patient app with advanced engagement features | Comparable |
| Remote eConsent (home-based) | Home-based, video-assisted, in-person options; full audit | Yes; integrated with patient engagement platform | Comparable |
| RTSM | Native randomization (variable block, stratification, blinding controls). Trial supply / kit logistics via partner integration. | Typically integrated third-party | Castor |
| Telehealth / video visit scheduling | Supported via third-party telehealth integration; partners readily available | Native scheduling; integrated video platform; strong UX | Specialist feature |
| Home health coordination (nursing, labs) | Supported via integration with home health vendors; flexible partnership model | Native ecosystem; coordinates home nursing, phlebotomy, specimens | Specialist feature |
| Wearable and sensor integration | API-based integration available; standard wearable platforms supported | Advanced; native integrations with major wearable platforms | Specialist feature |
| EU MDR / PMCF support | Excellent; built for EU regulatory requirements | Not publicly documented | Castor |
| RWE / registry support | Native RWE module; registry-ready | Limited; typically integrated | Castor |
| Pricing transparency | Predictable flat-rate study licensing, no per-subject fees | Pricing not publicly disclosed | Castor |
| Setup complexity | Lower; weeks vs. months; built-in no-code tools | Higher; multiple integration points | Castor |
| Academic / IIT support | Strong; pricing for academic research | Limited; enterprise-focused | Castor |
Castor is a cloud-native, unified clinical research platform built from the ground up to support both traditional and decentralised trial designs. Headquartered in Amsterdam and operating in 160+ countries (cumulative, to date), Castor combines EDC, eCOA, eConsent, native randomization, and RWE; all natively integrated, with no additional integrations needed.
Medable is a US-headquartered (Palo Alto, CA) “patient-first” decentralised clinical trial platform. Founded 2015, Medable has significant investor backing and positions itself as a specialist in running fully decentralised studies, with emphasis on patient engagement, recruitment, and home-based care coordination.
Some of the most sophisticated DCT programmes use multiple vendors: Castor for centralised EDC and data management, a specialist like Medable (or a home health network partner) for home logistics and patient coordination, and a third system for CTMS or patient recruitment. This is the right approach when your protocol requires both centralised data governance and complex home-based logistics.
Medable is primarily used for fully or partially decentralised clinical trials where patients participate from home. Its platform coordinates remote data collection (via a patient app), telemedicine visits, home health services (home nursing, phlebotomy), and wearable data integration. It is particularly strong for patient recruitment, retention, and logistics coordination.
Yes, Castor supports decentralised clinical trials, but it also supports traditional and hybrid designs. Castor is a unified EDC plus eCOA plus eConsent plus randomization platform equally suited to on-site, hybrid, and fully remote trial designs. Its decentralised capabilities are strong, but it is not exclusively a DCT platform.
Medable has EDC capabilities, but EDC is not its core strength. Many Medable implementations integrate Medable’s eCOA and home logistics layer with a third-party EDC system for centralised data management. If you need Medable primarily for its home health coordination and patient engagement features, you may still need a separate EDC partner.
Castor is typically the better choice for hybrid trials. Castor’s unified platform handles on-site monitoring, remote eCOA, eConsent, and EDC without integration overhead. Medable’s strength is in fully decentralised programmes with home logistics. For hybrid designs, you would pay for capabilities (home nursing coordination, telehealth scheduling) that may not be essential.
Home health coordination in platforms like Medable involves integrating with networks of home health vendors (home nursing agencies, phlebotomy services, specimen collection). The platform schedules visits, manages patient preferences, coordinates logistics, and captures data from home visits within a single patient-facing interface. Castor does not natively integrate home health coordination. This is a gap for purely decentralised programmes with home visit requirements.